Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Eli, spanning July 23, 2026 through September 21, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 13 article observations and 13 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Eli Lilly's retatrutide shows promising results in weight loss trials, driving stock gains and regulatory anticipation